Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - LYONS GARY A
Last Updated 
10-Oct-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

LYONS GARY A: Declared Holdings
Company/RelationshipReportedShares  Ownership
Cytori Therapeutics Inc
Director
NasdaqGM:CYTX
(historical quotes, profile, other insiders)
19-May-1424,409  Direct
Neurocrine Biosciences, Inc.
Director
NasdaqGS:NBIX
(historical quotes, profile, SEC, other insiders)
15-Sep-14284,164  Direct
Retrophin, Inc.
Director
NasdaqGM:RTRX
(historical quotes, profile, other insiders)
8-Oct-1420,000  Direct
Vical Incorporated
Director
NasdaqGS:VICL
(historical quotes, profile, SEC, other insiders)
22-May-1470,781  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
8-Oct-14 20,000RTRX Acquisition (Non Open Market) at $0 per share.
15-Sep-14 20,000NBIX Automatic Sale at $15.66 per share.
(Proceeds of $313,200)
22-May-14 7,500VICL Acquisition (Non Open Market) at $0.01 per share.
(Value of $75)
19-May-14 3,409CYTX Acquisition (Non Open Market) at $0 per share.
7-Mar-14 85,000NBIX Option Exercise at $10.98 per share.
(Cost of $933,300)
7-Mar-14 53,331NBIX Disposition (Non Open Market) at $17.50 per share.
(Value of $933,292)
7-Oct-13 21,000CYTX Acquisition (Non Open Market) at $0 per share.
23-May-13 5,953VICL Purchase at $0.01 per share.
(Cost of $59)

 

 


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?